Opus Genetics
Likely to Engage tag.Highly Engaged Employees

Manufacturing · North Carolina, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

8 Davis Dr Ste 220, Durham, North Caroli...

Phone Number

(984) 884-6030

Revenue

$9.9 Million

Stock Symbol

IRD

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Opus Genetics

Opus Genetics is a clinical-stage biopharmaceutical company in the biotechnology and ophthalmology industry, focused on developing innovative gene therapies for inherited retinal diseases and other retinal and refractive disorders. Headquartered in the United States, the company conducts research and development in ophthalmic gene therapies and is dedicated to creating treatments that correct or compensate for genetic defects causing retinal degeneration. Opus Genetics aims to deliver durable, vision-preserving and vision-restoring therapies, translating scientific breakthroughs into safe and effective solutions for patients with rare and common retinal conditions, while striving to lead global innovation in ophthalmic gene therapy.Explore more
Opus Genetics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: IRDShow more

Opus Genetics Org Chart

GM
United States flag for contact location.

Chief Executive Officer & Board Member

PhoneEmail
JS
United States flag for contact location.

Chief Operating Officer

PhoneEmail
BY
United States flag for contact location.

President

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
CH
United States flag for contact location.

Senior VP, Corporate Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Opus Genetics

Compare insights from companies similar to Opus Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Opus Genetics

$9.9M
11-50
Public
$164.4M
2021
GM
George MagrathCEO & Board Member
$5.9M
1-10
Private
<$5M
2021
AC
Andy ConnerCo-Founder & Head of Product
$5.6M
11-50
Private
-
-
<$5M
1-10
Private
-
2022
JS
Jason SimpsonNational Account Manager
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2015
N/A
Illustration of an envelope

Opus Genetics Tech Stack

A closer look at the technologies used by Opus Genetics

Top Manufacturing Companies

Frequently Asked Questions Regarding Opus Genetics

What is Opus Genetics's stock symbol?
Opus Genetics's stock symbol is IRD
What is Opus Genetics's official website?
Opus Genetics's official website is www.opusgtx.com
What is Opus Genetics's Revenue?
Opus Genetics's revenue is $9.9 Million
What is Opus Genetics's SIC code?
Opus Genetics's SIC: 28,283
What is Opus Genetics's NAICS code?
Opus Genetics's NAICS: 32,325
How many employees does Opus Genetics have?
Opus Genetics has 11-50 employees
What industry does Opus Genetics belong to?
Opus Genetics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Opus Genetics competition?
Opus Genetics top competitors include: Sivility Systems, Foraged, Swift Creek Robotics, Kahalachildcare
What technology does Opus Genetics use?
Some of the popular technologies that Opus Genetics uses are: PHP, Cloudflare Website Optimization, YouTube, QuickBooks
How do I contact Opus Genetics?
Opus Genetics contact info: Phone number: (984) 884-6030 Website: www.opusgtx.com
What does Opus Genetics do?

Opus Genetics is a clinical-stage biopharmaceutical company in the biotechnology and ophthalmology industry, focused on developing innovative gene therapies for inherited retinal diseases and other retinal and refractive disorders. Headquartered in the United States, the company conducts research and development in ophthalmic gene therapies and is... dedicated to creating treatments that correct or compensate for genetic defects causing retinal degeneration. Opus Genetics aims to deliver durable, vision-preserving and vision-restoring therapies, translating scientific breakthroughs into safe and effective solutions for patients with rare and common retinal conditions, while striving to lead global innovation in ophthalmic gene therapy.Read More

What are Opus Genetics social media links?
Opus Genetics Linkedin page Opus Genetics Twitter page
Who invested in Opus Genetics?
Opus Genetics has 2 investors including Oberland Capital and North Carolina Biotechnology Center.
Is Opus Genetics a public company?
Yes, Opus Genetics is a public company and is traded under the symbol IRD
See more information about Opus Genetics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.